The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.

Ryoko Sakai Yukiko Komano Michi Tanaka Toshihiro Nanki Ryuji Koike Atsuo Nakajima Tatsuya Atsumi Shinsuke Yasuda Yoshiya Tanaka Kazuyoshi Saito Shigeto Tohma Takao Fujii Atsushi Ihata Naoto Tamura Atsushi Kawakami Takahiko Sugihara Satoshi Ito Nobuyuki Miyasaka Masayoshi Harigai

Mod Rheumatol

Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Bunkyo-ku, Yushima, Tokyo, 113-8519, Japan.

Published: August 2011

Download full-text PDF	Source
http://dx.doi.org/10.1007/s10165-011-0421-z	DOI Listing

Publication Analysis

Top Keywords

real database

database reveals

reveals risk

risk serious

serious infection

infection treatment

treatment methotrexate

methotrexate dose

dose 8 mg/week

8 mg/week patients

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?